Bavarian Nordic

Scalable Life Sciences supports Bavarian Nordic in the areas of market acces en public affairs.

Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer
immunotherapies and vaccines for infectious diseases.

Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases
by leveraging several core strengths:

  • Extensive R&D expertise in vaccines and immunotherapy
  • Broadly applicable platform technology
  • Multiple clinical stage development programs, including two Phase 3 trials
  • Flexible, commercial scale manufacturing facility
  • Significant financial resources resulting from IMVAMUNE® supply contracts and government-funded R&D

Corporate Communications, Investor Relations and Public Affairs for Life Sciences